Published • loading... • Updated
Professor Gordon Guyatt Discusses Evidence-Based Medicine, Ozempic Safety, Weight-Loss Challenges & AI-Driven Guideline Evolution
Summary by In-sightpublishing.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Professor Gordon Guyatt Discusses Evidence-Based Medicine, Ozempic Safety, Weight-Loss Challenges & AI-Driven Guideline Evolution
Author(s): Scott Douglas Jacobsen Publication (Outlet/Website): A Further Inquiry Publication Date (yyyy/mm/dd): 2025/08/13 Professor Gordon Guyatt is a Canadian physician, health researcher, and Distinguished Professor at McMaster University, widely recognized as the pioneer of evidence-based medicine (EBM). He coined the term “evidence-based medicine” in 1991, fundamentally transforming how clinicians worldwide evaluate research and make patie…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
